» Articles » PMID: 23904770

Management of Penoscrotal Extramammary Paget Disease: Case Series and Review of the Literature

Overview
Journal Curr Oncol
Publisher MDPI
Specialty Oncology
Date 2013 Aug 2
PMID 23904770
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Extramammary Paget disease (empd) is a rare, slow-growing neoplasm, considered to be an adenocarcinoma of the apocrine glands. In men, the penoscrotal region is the most commonly affected area. The disease can present as carcinoma in situ or as invasive disease that can subsequently metastasize to lymph nodes and distant sites. Because of the rarity of empd, the medical literature available to guide management of the disease is limited, particularly in patients with metastases. In addition, metastatic disease may pose a diagnostic challenge, because invasive cancer of the genitourinary or gastrointestinal tract can occur in association with empd. In the present case series, we describe our experience in treating penoscrotal empd with multimodality therapy, and we review the existing literature concerning its diagnosis and management.

Citing Articles

Long-Term Complete Response and Survival in Metastatic Extramammary Paget's Disease Treated With Trastuzumab Plus Paclitaxel: A Case Report.

Chilelli M, Signorelli C, Giron Berrios J, Raso A, Nelli F, Ruggeri E Cureus. 2024; 16(4):e58924.

PMID: 38800219 PMC: 11122668. DOI: 10.7759/cureus.58924.


Applications of photodynamic therapy in extramammary Paget's disease.

Ren F, Zhao S, Yang C, Liu J, Shang Q, Feng K Am J Cancer Res. 2023; 13(10):4492-4507.

PMID: 37970368 PMC: 10636668.


Extramammary Paget Disease: a Therapeutic Challenge, for a Rare Entity.

Perez J, Cortes Salgado A, Perez-Mies B, Rullan J, Ajuria-Illarramendi O, Alia E Curr Oncol Rep. 2023; 25(10):1081-1094.

PMID: 37421583 PMC: 10556167. DOI: 10.1007/s11912-023-01434-0.


Treatment outcomes of advanced/metastatic extramammary Paget's disease in Korean patients: KCSG-RC20-06.

Sohn B, Kim J, Kim M, Hong J, Lee J, Park S Cancer Med. 2023; 12(14):15159-15175.

PMID: 37264748 PMC: 10417073. DOI: 10.1002/cam4.6190.


Penile Paget's Disease: A Case Report and Review of the Literature.

Flanigan R, Dornbier R, Quek M, Woods M, Gorbonos A, Gupta G Arch Nephrol Urol. 2023; 3(4):90-96.

PMID: 36714463 PMC: 9884174. DOI: 10.26502/anu.2644-2833025.


References
1.
Hata M, Omura M, Koike I, Wada H, Miyagi E, Tayama Y . Role of radiotherapy as curative treatment of extramammary Paget's disease. Int J Radiat Oncol Biol Phys. 2010; 80(1):47-54. DOI: 10.1016/j.ijrobp.2010.01.073. View

2.
Ojeda V, Heenan P, WATSON S . Paget's disease of the groin associated with adenocarcinoma of the urinary bladder. J Cutan Pathol. 1987; 14(4):227-31. DOI: 10.1111/j.1600-0560.1987.tb01338.x. View

3.
Diaz de Leon E, Carcangiu M, Prieto V, McCue P, Burchette J, To G . Extramammary Paget disease is characterized by the consistent lack of estrogen and progesterone receptors but frequently expresses androgen receptor. Am J Clin Pathol. 2000; 113(4):572-5. DOI: 10.1309/P756-XXCB-TV71-U4XV. View

4.
Li Y, Lu L, Yang Y, Chang C, Chen L . Extramammary Paget's disease of the scrotum associated with hepatocellular carcinoma. J Chin Med Assoc. 2009; 72(10):542-6. DOI: 10.1016/S1726-4901(09)70425-3. View

5.
Ogawa T, Nagashima Y, Wada H, Akimoto K, Chiba Y, Nagatani T . Extramammary Paget's disease: analysis of growth signal pathway from the human epidermal growth factor receptor 2 protein. Hum Pathol. 2005; 36(12):1273-80. DOI: 10.1016/j.humpath.2005.09.009. View